XENETIC BIOSCIENCES INC (XBIO)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$4.67+0.86%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · XBIO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||
| Revenues | 3.3 | 3.0 | 2.5 | 2.5 | 1.7 | 1.2 | 0.4 | 0.0 | 0.0 | 7.6 | 3.0 | — | 0.0 | 1.0 | 0.1 |
| Total Revenues | 3.3 | 3.0 | 2.5 | 2.5 | 1.7 | 1.2 | 0.4 | 0.0 | 0.0 | 7.6 | 3.0 | — | 0.0 | 1.0 | 0.1 |
| Cost of Revenues | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | — |
| Gross Profit | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 1.0 | — |
| Operating Expenses & Income | |||||||||||||||
| R&D Expenses | 2.7 | 3.1 | 3.3 | 3.5 | 4.8 | 3.2 | 1.7 | 4.9 | 2.9 | 4.1 | 43.7 | 3.4 | 6.3 | 3.1 | — |
| Operating Income | (2.6) | (2.8) | (4.2) | (4.5) | (6.7) | (5.7) | (13.9) | (12.9) | (7.3) | (3.6) | (47.4) | (9.8) | (12.9) | (8.6) | (0.1) |
| Earnings from Continuing Operations | |||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | 0.0 | 0.7 | 0.3 | 0.0 | 0.0 | (0.0) |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | — |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | (0.0) | (0.0) | — |
| Other Non-Operating Income / Expenses | 0.2 | 0.2 | 0.2 | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | (0.0) | (0.0) | (6.8) | (2.7) | (1.4) | — | — |
| Asset Writedown | — | — | — | 0.0 | 0.0 | 0.0 | 9.2 | — | — | — | — | — | — | 0.0 | — |
| EBT, Incl. Unusual Items | — | — | — | — | — | — | — | — | — | — | — | — | (14.3) | (8.6) | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | (2.9) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
| Net Income | |||||||||||||||
| Net Income | (2.5) | (2.7) | (4.0) | (4.1) | (6.6) | (5.6) | (10.9) | (12.8) | (7.3) | (3.6) | (54.2) | (12.5) | (14.3) | (0.1) | (0.1) |
| Per Share | |||||||||||||||
| Basic EPS | (1.08) | (1.58) | (2.57) | (2.71) | (4.61) | (0.55) | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (1.08) | (1.58) | (2.57) | (2.71) | (4.61) | (0.55) | — | — | — | — | — | — | — | — | — |
| Revenue per Share | 1.42 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 2.3 | 1.7 | 1.5 | 1.5 | 1.4 | 10.3 | — | — | — | — | — | — | — | 135.0 | 144.2 |
| Diluted Weighted Avg Shares | 2.3 | 1.7 | 1.5 | 1.5 | 1.4 | 10.3 | — | — | — | — | — | — | — | — | — |
| Supplemental | |||||||||||||||
| EBITDA | — | — | — | — | (6.7) | (5.7) | (13.9) | — | — | — | — | (9.8) | (12.8) | — | — |
| EBIT | (2.6) | (2.8) | (4.2) | (4.5) | (6.7) | (5.7) | (13.9) | (12.9) | (7.3) | (3.6) | (47.4) | (9.8) | (12.9) | (8.6) | (0.1) |
| Effective Tax Rate | — | — | — | — | — | — | — | — | — | — | — | — | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.